Hemispherx Biopharma’s CFC Drug Reviewed In UK – Update – Trading Markets (press release)

by General Manager on 27th December 2007

in All ME/ Chronic Fatigue Syndrome And Fibromyalgia News

Hemispherx Biopharma’s CFC Drug Reviewed In UK – Update
Trading Markets (press release), CA
The report focuses on the growing problems in the UK related to Chronic Fatigue Syndrome. The Philadelphia, Pennsylvania based said the report for the UK

Hemispherx’s Chronic Fatigue Syndrome Clinical Programs Reviewed in European Community FOX News

 

Leave a Comment

Previous post:

Next post: